“Our strong first quarter 2025 financial results reflect the execution of our strategic plan to grow revenue and membership above-market rates, while continuing to drive profitability. First quarter 2025 medical costs are in line with expectations,” said Clover Health (CLOV) CFO Peter Kuipers. “Our results and strong underlying business fundamentals further reinforce our conviction in 2025, and we will continue to strategically invest into our growth model, manage our new and returning member cohorts, and expand Clover Assistant’s reach, to enhance our already strong competitive positioning in 2026 and beyond.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
- Clover Health options imply 11.0% move in share price post-earnings
- CLOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Clover Health Announces Board Leadership Change
- Clover Health appoints Shelly Gupta as Chief Medical Officer
- Insider Moves: Clean Energy, Warner Bros, Clover Health, Corning, TJX